Erez Kalir Buys Shares of VOR $VOR
Key Points
- Erez Kalir bought 57,162 shares of Vor Biopharma Inc. ($VOR).
- $VOR last traded around $14.36.
Erez Kalir, insider at Vor Biopharma Inc. ($VOR), bought 57,162 shares at an average price of $0.00. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Vor Biopharma Inc. ($VOR) Stock
Vor Biopharma Inc. Earnings
Analysts Set New Price Targets
About Vor Biopharma Inc.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.